Atai Life Sciences N.V.
(NQ:
ATAI
)
1.270
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
716,236
Open
1.300
Bid (Size)
1.250 (27)
Ask (Size)
1.310 (8)
Prev. Close
1.270
Today's Range
1.250 - 1.330
52wk Range
1.025 - 2.850
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
Today 7:45 EDT
These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.
Via
InvestorPlace
3 Psychedelic Stocks to Ride to the Moon and Beyond
July 06, 2024
Psychedelic stocks are a hot, trending area of investment as the FDA continues to weigh regulatory considerations that will open the market.
Via
InvestorPlace
Exposures
Product Safety
Performance
YTD
-24.85%
-24.85%
1 Month
-9.29%
-9.29%
3 Month
-51.15%
-51.15%
6 Month
-37.13%
-37.13%
1 Year
-43.30%
-43.30%
More News
Read More
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
July 03, 2024
Via
InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
Via
InvestorPlace
Clinical-Stage BioTech Drug Stocks Declined 13% In June
July 01, 2024
Via
Talk Markets
atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
June 26, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Via
Talk Markets
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
June 20, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
June 09, 2024
Via
Talk Markets
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
June 05, 2024
Via
Benzinga
Exposures
Product Safety
What's Going On With MindMed And Psychedelic Stocks?
June 05, 2024
Via
Benzinga
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
May 31, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
May 23, 2024
From
atai Life Sciences
Via
GlobeNewswire
ATAI Stock Earnings: ATAI Life Sciences Beats EPS for Q1 2024
May 15, 2024
Via
InvestorPlace
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
May 15, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
May 13, 2024
Via
Talk Markets
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
May 09, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
May 05, 2024
Via
Talk Markets
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
April 24, 2024
From
atai Life Sciences
Via
GlobeNewswire
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
April 23, 2024
Via
Talk Markets
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
April 19, 2024
Via
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Via
Benzinga
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
April 17, 2024
From
atai Life Sciences
Via
GlobeNewswire
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD
April 12, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.